SM
AZN icon

Samjo Management’s AstraZeneca AZN Stock Holding History

Samjo Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,665
Closed -$4.78M – 60
2026
Q1 		$4.78M Sell
24,665
-818
-3% -$158K 2.07% 14
2025
Q4 		$4.69M Sell
25,483
-945
-4% -$166K 1.81% 20
2025
Q3 		$4.06M Sell
26,428
-725
-3% -$110K 1.55% 20
2025
Q2 		$3.79M Sell
27,153
-125
-0.5% -$17.5K 1.6% 19
2025
Q1 		$4.01M Sell
27,278
-50
-0.2% -$7.23K 1.7% 21
2024
Q4 		$3.58M Sell
27,328
-250
-0.9% -$35K 1.35% 23
2024
Q3 		$4.3M Buy
27,578
+8
+0% +$1.29K 1.48% 16
2024
Q2 		$4.3M Sell
27,570
-33
-0.1% -$4.97K 1.6% 14
2024
Q1 		$3.74M Buy
27,603
+2,138
+8% +$283K 1.32% 14
2023
Q4 		$3.43M Buy
+25,465
New +$3.31M 1.21% 15

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Samjo Management's AZN Position: Q2 2026 in Review

Samjo Management sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 24,665 shares — an estimated $4.78M sold.

Samjo Management first reported a position in AZN in Q4 2023 and held it in 10 quarters. The position peaked at $4.78M in Q1 2026. 1,501 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Samjo Management reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Samjo Management sold 24,665 AstraZeneca shares in Q2 2026, an estimated $4.78M.
  • Samjo Management first reported a position in AstraZeneca in Q4 2023 and held it in 10 quarters.
  • Samjo Management's AstraZeneca position peaked at $4.78M in Q1 2026.
  • 1,501 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Samjo Management's 13F filing for Q2 2026, filed 14 Aug 2026.